Robert W. Pangia

Manufactures chocolates and sugar candies.

Provides oil and gas production services

Provides stock brokerage and asset management services

Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases

Manufactures osteosynthesis devices and products

Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments.

Ivy Capital Partners LLC invests in companies located in the United States. The firm targets companies operating in the fields of orthopedic, rehabilitation products and sports medicine under the healthcare industry. It provides equity financing for growth stage capital requirements.

Provides wound care and hyperbaric oxygen therapy services

Engages in the development and testing technologies for the minimally invasive treatments

Paine Webber Properties, Inc. is an American company.

Provides investment banking services

Discovers, develops, manufactures and supplies pharmaceutical products

Distributes silk based biomaterial products for tissue rejuvenation

Develops and produces meniscus implants

Functions as a College/University

Operates medical dermal filler company

Manufactures activated silk